Lead Sponsor

Novo Nordisk A/S

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

No

•Either - Black or African American not of Hispanic or Latino origin or - White of Hispanic or Latino origin or - White not of Hispanic or Latino origin
•Type 2 diabetes mellitus (as diagnosed clinically) for at least 12 months
•Treated with insulin for at least 3 months, alone or in combination with maximum 2 oral antidiabetic drugs (OADs)
•Body mass index maximum 40.0 kg/m\^2

•Use of GLP-1 receptor agonists (exenatide, liraglutide), thiazolidinediones or dipeptidyl peptidase-4 (DPP-4) inhibitors within 3 months prior to screening
•History of multiple and/or severe allergies to drugs or foods or a history of severe anaphylactic reaction
•Subject who has donated any blood or plasma in the past month or more than 500 mL within 3 months prior to screening